Abstract
Background and Aims : Familial dysbetalipoproteinemia (FD, type III hyperlipoproteinemia) is an AR inherited disease associated with APOE polymorphism. The typical genotype of FD is APOE2/2 and the phenotype mixed DLP arising in the context of other unknown metabolic or genetic factors. The aim of this work was to determine the hypertriglyceridemic (HTG) score in patients with FD, as a possible determinant of FD development.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
